Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114853711A reveals a novel copper-catalyzed one-pot method for converting CBD to CBN, offering significant cost reduction and scalability for pharmaceutical manufacturers.
Novel Pd-catalyzed domino reaction for indole derivatives. Mild conditions, high yield, scalable for pharma intermediates. Reliable supply chain solutions.
Patent CN108048438B reveals a novel halohydrin dehalogenase mutant for efficient Atorvastatin side chain synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1044278A details a novel epoxidation route for cis-glycidols using sulfonium ylides, offering improved stereoselectivity and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN101768141A details a safer solvent-free synthesis route. Achieve high purity and reduced environmental impact for pharmaceutical intermediate supply chains.
Novel gamma-butyrolactone route for 3-hydroxymethyl tetrahydrofuran. High yield, low cost agrochemical intermediate manufacturing process suitable for industrial scale-up.
Patent CN108191729A reveals eco-friendly thiosulfonate synthesis enabling cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable production capabilities.
Patent CN102250077B reveals a mild, scalable route for rivaroxaban intermediates, offering significant cost reduction and supply chain reliability for global API manufacturers.
Patent CN116239645B reveals a high-yield photochemical route for Dydrogesterone. Discover cost-effective manufacturing and reliable supply chain solutions.
Explore novel macrocyclic TRK/ALK/ROS1 inhibitors from patent CN111171049B. Overcome drug resistance with high-purity pharmaceutical intermediates and scalable synthesis routes.
Patent CN1709864A discloses a high-yield asymmetric synthesis for Taxol side chains using low-cost glycolic acid and chiral tert-butyl sulfinamide, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN110981719A reveals a novel route for 3-carboxybenzaldehyde using m-tolunitrile. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101104609B discloses a mild reductive amination route for Solanesyl polyamine derivatives, offering high yields and scalable production for oncology drug discovery.
Discover the advanced atmospheric pressure synthesis of (2S)-indoline-2-carboxylic acid. A cost-effective, high-purity route for Perindopril intermediates suitable for industrial scale-up.
Patent CN111548317A reveals a novel Efavirenz synthesis using Zinc Chloride, offering significant cost reduction and improved yield for pharmaceutical intermediate manufacturing.
Novel patent CN104557793B offers high-yield Carfilzomib intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Advanced synthesis patent CN107721815A enables high-purity pharmaceutical intermediates with significant cost reduction and supply chain reliability for global buyers.
Patent CN116143621A reveals a green boron salt catalytic method for converting benzamides to esters. This technology offers high purity, metal-free synthesis for reliable pharmaceutical intermediate supply chains.
Efficient one-step coupling method for 1-aryl-2-tetralones using ferrocene-palladium catalysts. Reduces synthetic steps and improves regioselectivity for pharmaceutical intermediates.
Novel patent CN116731087A offers high-yield Molnupiravir synthesis. Reduces toxic waste and enhances supply chain reliability for global pharmaceutical manufacturers.